{"entity":{"type":"insider","cik":"0001257444","url":"/insider/0001257444","json_url":"/insider/0001257444.json","name":"ALTA BIOPHARMA PARTNERS III LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":12,"first":"2004-10-19","last":"2014-02-05","span_basis":"filed_date"},"name_variants":[{"name":"ALTA BIOPHARMA PARTNERS III LP","source":"filing","n_filings":12,"first_seen":"2004-10-19","last_seen":"2014-02-05"}],"transactions":[{"id":6344652,"accession":"0001209191-14-007595","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-14-007595","line_url":"/filing/0001209191-14-007595#line-9","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":103330.0,"shares_display":"103,330","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1136630.0,"total_display":"1,136,630.00","shares_owned_after":1753447.0,"shares_owned_after_display":"1,753,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-05","scope":"insider"},{"id":6344647,"accession":"0001209191-14-007595","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-14-007595","line_url":"/filing/0001209191-14-007595#line-8","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6940.0,"shares_display":"6,940","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":76340.0,"total_display":"76,340.00","shares_owned_after":117760.0,"shares_owned_after_display":"117,760","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-05","scope":"insider"},{"id":6344641,"accession":"0001209191-14-007595","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-007595","line_url":"/filing/0001209191-14-007595#line-7","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Cara Therapeutics, Inc.","issuer_ticker":"CARA","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2547.0,"shares_display":"2,547","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":28017.0,"total_display":"28,017.00","shares_owned_after":43212.0,"shares_owned_after_display":"43,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-05","scope":"insider"},{"id":2163996,"accession":"0001209191-12-049852","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-12-049852","line_url":"/filing/0001209191-12-049852#line-6","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; HURWITZ EDWARD; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; Kiley Alison","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128229.0,"shares_display":"128,229","price_per_share":18.67,"price_display":"18.67","price_state":"stated","total_value":2394035.43,"total_display":"2,394,035.43","shares_owned_after":2280197.0,"shares_owned_after_display":"2,280,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-16","filed_date":"2012-10-17","scope":"insider"},{"id":2163992,"accession":"0001209191-12-049852","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-12-049852","line_url":"/filing/0001209191-12-049852#line-5","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; HURWITZ EDWARD; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; Kiley Alison","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8611.0,"shares_display":"8,611","price_per_share":18.67,"price_display":"18.67","price_state":"stated","total_value":160767.37,"total_display":"160,767.37","shares_owned_after":153131.0,"shares_owned_after_display":"153,131","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-10-16","filed_date":"2012-10-17","scope":"insider"},{"id":2163987,"accession":"0001209191-12-049852","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-12-049852","line_url":"/filing/0001209191-12-049852#line-4","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; HURWITZ EDWARD; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; Kiley Alison","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3160.0,"shares_display":"3,160","price_per_share":18.67,"price_display":"18.67","price_state":"stated","total_value":58997.2,"total_display":"58,997.20","shares_owned_after":56190.0,"shares_owned_after_display":"56,190","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-10-16","filed_date":"2012-10-17","scope":"insider"},{"id":2163985,"accession":"0001209191-12-049852","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-049852","line_url":"/filing/0001209191-12-049852#line-3","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; HURWITZ EDWARD; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; Kiley Alison","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55626.0,"shares_display":"55,626","price_per_share":17.54,"price_display":"17.54","price_state":"stated","total_value":975680.04,"total_display":"975,680.04","shares_owned_after":2408426.0,"shares_owned_after_display":"2,408,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-15","filed_date":"2012-10-17","scope":"insider"},{"id":2163981,"accession":"0001209191-12-049852","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-049852","line_url":"/filing/0001209191-12-049852#line-2","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; HURWITZ EDWARD; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; Kiley Alison","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3736.0,"shares_display":"3,736","price_per_share":17.54,"price_display":"17.54","price_state":"stated","total_value":65529.44,"total_display":"65,529.44","shares_owned_after":161742.0,"shares_owned_after_display":"161,742","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-10-15","filed_date":"2012-10-17","scope":"insider"},{"id":2163978,"accession":"0001209191-12-049852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-049852","line_url":"/filing/0001209191-12-049852#line-1","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; HURWITZ EDWARD; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; Kiley Alison","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1371.0,"shares_display":"1,371","price_per_share":17.54,"price_display":"17.54","price_state":"stated","total_value":24047.34,"total_display":"24,047.34","shares_owned_after":59350.0,"shares_owned_after_display":"59,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-10-15","filed_date":"2012-10-17","scope":"insider"},{"id":9018918,"accession":"0001209191-11-043220","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-11-043220","line_url":"/filing/0001209191-11-043220#line-6","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5038.0,"shares_display":"5,038","price_per_share":12.454,"price_display":"12.45","price_state":"stated","total_value":62743.252,"total_display":"62,743.25","shares_owned_after":2464052.0,"shares_owned_after_display":"2,464,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-09","scope":"insider"},{"id":9018917,"accession":"0001209191-11-043220","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-11-043220","line_url":"/filing/0001209191-11-043220#line-5","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":338.0,"shares_display":"338","price_per_share":12.454,"price_display":"12.45","price_state":"stated","total_value":4209.452,"total_display":"4,209.45","shares_owned_after":165478.0,"shares_owned_after_display":"165,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-09","scope":"insider"},{"id":9018916,"accession":"0001209191-11-043220","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-11-043220","line_url":"/filing/0001209191-11-043220#line-4","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":124.0,"shares_display":"124","price_per_share":12.454,"price_display":"12.45","price_state":"stated","total_value":1544.296,"total_display":"1,544.30","shares_owned_after":60721.0,"shares_owned_after_display":"60,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-09","scope":"insider"},{"id":9018915,"accession":"0001209191-11-043220","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-043220","line_url":"/filing/0001209191-11-043220#line-3","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3847.0,"shares_display":"3,847","price_per_share":12.4296,"price_display":"12.43","price_state":"stated","total_value":47816.6712,"total_display":"47,816.67","shares_owned_after":2459014.0,"shares_owned_after_display":"2,459,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-08","filed_date":"2011-08-09","scope":"insider"},{"id":9018914,"accession":"0001209191-11-043220","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-043220","line_url":"/filing/0001209191-11-043220#line-2","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":258.0,"shares_display":"258","price_per_share":12.4296,"price_display":"12.43","price_state":"stated","total_value":3206.8368,"total_display":"3,206.84","shares_owned_after":165140.0,"shares_owned_after_display":"165,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-08","filed_date":"2011-08-09","scope":"insider"},{"id":9018913,"accession":"0001209191-11-043220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-043220","line_url":"/filing/0001209191-11-043220#line-1","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA MANAGEMENT III LLC; PENHOET EDWARD; HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":95.0,"shares_display":"95","price_per_share":12.4296,"price_display":"12.43","price_state":"stated","total_value":1180.812,"total_display":"1,180.81","shares_owned_after":60597.0,"shares_owned_after_display":"60,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-08","filed_date":"2011-08-09","scope":"insider"},{"id":7564676,"accession":"0001209191-10-051904","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-10-051904","line_url":"/filing/0001209191-10-051904#line-12","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; PENHOET EDWARD; HURWITZ EDWARD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":289236.0,"shares_display":"289,236","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":2747742.0,"total_display":"2,747,742.00","shares_owned_after":2455167.0,"shares_owned_after_display":"2,455,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-27","filed_date":"2010-10-27","scope":"insider"},{"id":7564674,"accession":"0001209191-10-051904","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-10-051904","line_url":"/filing/0001209191-10-051904#line-11","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; PENHOET EDWARD; HURWITZ EDWARD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19425.0,"shares_display":"19,425","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":184537.5,"total_display":"184,537.50","shares_owned_after":164882.0,"shares_owned_after_display":"164,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-27","filed_date":"2010-10-27","scope":"insider"},{"id":7564672,"accession":"0001209191-10-051904","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-10-051904","line_url":"/filing/0001209191-10-051904#line-10","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; PENHOET EDWARD; HURWITZ EDWARD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7128.0,"shares_display":"7,128","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":67716.0,"total_display":"67,716.00","shares_owned_after":60502.0,"shares_owned_after_display":"60,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-27","filed_date":"2010-10-27","scope":"insider"},{"id":7244333,"accession":"0001209191-10-036944","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-10-036944","line_url":"/filing/0001209191-10-036944#line-6","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"PENHOET EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; DELEAGE JEAN; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10910596.0,"shares_display":"10,910,596","price_per_share":0.275,"price_display":"0.28","price_state":"stated","total_value":3000413.9,"total_display":"3,000,413.90","shares_owned_after":10910596.0,"shares_owned_after_display":"10,910,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-30","filed_date":"2010-07-02","scope":"insider"},{"id":7244331,"accession":"0001209191-10-036944","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-10-036944","line_url":"/filing/0001209191-10-036944#line-5","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"PENHOET EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; DELEAGE JEAN; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":732745.0,"shares_display":"732,745","price_per_share":0.275,"price_display":"0.28","price_state":"stated","total_value":201504.875,"total_display":"201,504.88","shares_owned_after":732745.0,"shares_owned_after_display":"732,745","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-30","filed_date":"2010-07-02","scope":"insider"},{"id":7244329,"accession":"0001209191-10-036944","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-036944","line_url":"/filing/0001209191-10-036944#line-4","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"PENHOET EDWARD; ALTA BIOPHARMA PARTNERS III LP; CHAMPSI FARAH; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; DELEAGE JEAN; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":268883.0,"shares_display":"268,883","price_per_share":0.275,"price_display":"0.28","price_state":"stated","total_value":73942.825,"total_display":"73,942.82","shares_owned_after":268883.0,"shares_owned_after_display":"268,883","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-30","filed_date":"2010-07-02","scope":"insider"},{"id":5638085,"accession":"0001209191-09-057467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-057467","line_url":"/filing/0001209191-09-057467#line-3","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; DELEAGE JEAN; PENHOET EDWARD; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stocks","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2044750.0,"shares_display":"2,044,750","price_per_share":2.0094,"price_display":"2.01","price_state":"stated","total_value":4108720.65,"total_display":"4,108,720.65","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-14","filed_date":"2009-12-16","scope":"insider"},{"id":5638084,"accession":"0001209191-09-057467","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-057467","line_url":"/filing/0001209191-09-057467#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; DELEAGE JEAN; PENHOET EDWARD; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stocks","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":137323.0,"shares_display":"137,323","price_per_share":2.0094,"price_display":"2.01","price_state":"stated","total_value":275936.8362,"total_display":"275,936.84","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-14","filed_date":"2009-12-16","scope":"insider"},{"id":5638083,"accession":"0001209191-09-057467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-057467","line_url":"/filing/0001209191-09-057467#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; DELEAGE JEAN; PENHOET EDWARD; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stocks","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50391.0,"shares_display":"50,391","price_per_share":2.0094,"price_display":"2.01","price_state":"stated","total_value":101255.6754,"total_display":"101,255.68","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-14","filed_date":"2009-12-16","scope":"insider"},{"id":5711657,"accession":"0001209191-09-047812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-047812","line_url":"/filing/0001209191-09-047812#line-3","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"HURWITZ EDWARD; PENHOET EDWARD; DELEAGE JEAN; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA BIOPHARMA MANAGEMENT III LLC; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":239768.0,"shares_display":"239,768","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":457956.88,"total_display":"457,956.88","shares_owned_after":1439921.0,"shares_owned_after_display":"1,439,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-05","filed_date":"2009-10-06","scope":"insider"},{"id":5711656,"accession":"0001209191-09-047812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-047812","line_url":"/filing/0001209191-09-047812#line-2","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"HURWITZ EDWARD; PENHOET EDWARD; DELEAGE JEAN; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA BIOPHARMA MANAGEMENT III LLC; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16103.0,"shares_display":"16,103","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":30756.73,"total_display":"30,756.73","shares_owned_after":96704.0,"shares_owned_after_display":"96,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-10-05","filed_date":"2009-10-06","scope":"insider"},{"id":5711655,"accession":"0001209191-09-047812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-047812","line_url":"/filing/0001209191-09-047812#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"HURWITZ EDWARD; PENHOET EDWARD; DELEAGE JEAN; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA BIOPHARMA MANAGEMENT III LLC; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5909.0,"shares_display":"5,909","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":11286.19,"total_display":"11,286.19","shares_owned_after":35485.0,"shares_owned_after_display":"35,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-10-05","filed_date":"2009-10-06","scope":"insider"},{"id":5665673,"accession":"0001209191-09-043545","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-12","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":238256.0,"shares_display":"238,256","price_per_share":0.2195,"price_display":"0.22","price_state":"stated","total_value":52297.192,"total_display":"52,297.19","shares_owned_after":853026.0,"shares_owned_after_display":"853,026","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-08","filed_date":"2009-09-08","scope":"insider"},{"id":5665672,"accession":"0001209191-09-043545","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-11","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103618.0,"shares_display":"103,618","price_per_share":0.2195,"price_display":"0.22","price_state":"stated","total_value":22744.151,"total_display":"22,744.15","shares_owned_after":370985.0,"shares_owned_after_display":"370,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-08","filed_date":"2009-09-08","scope":"insider"},{"id":5665671,"accession":"0001209191-09-043545","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-10","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67879.0,"shares_display":"67,879","price_per_share":0.2195,"price_display":"0.22","price_state":"stated","total_value":14899.4405,"total_display":"14,899.44","shares_owned_after":243025.0,"shares_owned_after_display":"243,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-08","filed_date":"2009-09-08","scope":"insider"},{"id":5665670,"accession":"0001209191-09-043545","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-9","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6959.0,"shares_display":"6,959","price_per_share":0.2195,"price_display":"0.22","price_state":"stated","total_value":1527.5005,"total_display":"1,527.50","shares_owned_after":24914.0,"shares_owned_after_display":"24,914","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-08","filed_date":"2009-09-08","scope":"insider"},{"id":5665669,"accession":"0001209191-09-043545","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-8","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3010.0,"shares_display":"3,010","price_per_share":0.2195,"price_display":"0.22","price_state":"stated","total_value":660.695,"total_display":"660.70","shares_owned_after":10776.0,"shares_owned_after_display":"10,776","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-08","filed_date":"2009-09-08","scope":"insider"},{"id":5665668,"accession":"0001209191-09-043545","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-7","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2553.0,"shares_display":"2,553","price_per_share":0.2195,"price_display":"0.22","price_state":"stated","total_value":560.3835,"total_display":"560.38","shares_owned_after":9143.0,"shares_owned_after_display":"9,143","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-08","filed_date":"2009-09-08","scope":"insider"},{"id":5665667,"accession":"0001209191-09-043545","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-6","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166762.0,"shares_display":"166,762","price_per_share":0.2327,"price_display":"0.23","price_state":"stated","total_value":38805.5174,"total_display":"38,805.52","shares_owned_after":1091282.0,"shares_owned_after_display":"1,091,282","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-03","filed_date":"2009-09-08","scope":"insider"},{"id":5665666,"accession":"0001209191-09-043545","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-5","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72525.0,"shares_display":"72,525","price_per_share":0.2327,"price_display":"0.23","price_state":"stated","total_value":16876.5675,"total_display":"16,876.57","shares_owned_after":474603.0,"shares_owned_after_display":"474,603","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-03","filed_date":"2009-09-08","scope":"insider"},{"id":5665665,"accession":"0001209191-09-043545","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-4","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47510.0,"shares_display":"47,510","price_per_share":0.2327,"price_display":"0.23","price_state":"stated","total_value":11055.577,"total_display":"11,055.58","shares_owned_after":310904.0,"shares_owned_after_display":"310,904","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-03","filed_date":"2009-09-08","scope":"insider"},{"id":5665664,"accession":"0001209191-09-043545","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-3","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4871.0,"shares_display":"4,871","price_per_share":0.2327,"price_display":"0.23","price_state":"stated","total_value":1133.4817,"total_display":"1,133.48","shares_owned_after":31873.0,"shares_owned_after_display":"31,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-03","filed_date":"2009-09-08","scope":"insider"},{"id":5665663,"accession":"0001209191-09-043545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-2","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2107.0,"shares_display":"2,107","price_per_share":0.2327,"price_display":"0.23","price_state":"stated","total_value":490.2989,"total_display":"490.30","shares_owned_after":13786.0,"shares_owned_after_display":"13,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-03","filed_date":"2009-09-08","scope":"insider"},{"id":5665662,"accession":"0001209191-09-043545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-043545","line_url":"/filing/0001209191-09-043545#line-1","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"TorreyPines Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS III LP; HURWITZ EDWARD; PENHOET EDWARD; Alta Partners III, Inc.; DELEAGE JEAN; ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; CHAMPSI FARAH","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1787.0,"shares_display":"1,787","price_per_share":0.2327,"price_display":"0.23","price_state":"stated","total_value":415.8349,"total_display":"415.83","shares_owned_after":12056.0,"shares_owned_after_display":"12,056","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-03","filed_date":"2009-09-08","scope":"insider"},{"id":1484170,"accession":"0001209191-05-052704","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-052704","line_url":"/filing/0001209191-05-052704#line-3","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"GRUENER GARRETT; MARDUEL ALIX; PENHOET EDWARD; NOHRA GUY P; HURWITZ EDWARD; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA PARTNERS II INC; DELEAGE JEAN; Alta Partners III, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152900.0,"shares_display":"152,900","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":1987700.0,"total_display":"1,987,700.00","shares_owned_after":869164.0,"shares_owned_after_display":"869,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-14","filed_date":"2005-10-18","scope":"insider"},{"id":1484169,"accession":"0001209191-05-052704","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-052704","line_url":"/filing/0001209191-05-052704#line-2","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"GRUENER GARRETT; MARDUEL ALIX; PENHOET EDWARD; NOHRA GUY P; HURWITZ EDWARD; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA PARTNERS II INC; DELEAGE JEAN; Alta Partners III, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10268.0,"shares_display":"10,268","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":133484.0,"total_display":"133,484.00","shares_owned_after":58370.0,"shares_owned_after_display":"58,370","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-14","filed_date":"2005-10-18","scope":"insider"},{"id":1484168,"accession":"0001209191-05-052704","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-05-052704","line_url":"/filing/0001209191-05-052704#line-1","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"GRUENER GARRETT; MARDUEL ALIX; PENHOET EDWARD; NOHRA GUY P; HURWITZ EDWARD; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA PARTNERS II INC; DELEAGE JEAN; Alta Partners III, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3769.0,"shares_display":"3,769","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":48997.0,"total_display":"48,997.00","shares_owned_after":21415.0,"shares_owned_after_display":"21,415","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-14","filed_date":"2005-10-18","scope":"insider"},{"id":1481826,"accession":"0001209191-05-052406","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-052406","line_url":"/filing/0001209191-05-052406#line-3","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; ALTA PARTNERS II INC; MARDUEL ALIX; CHAMPSI FARAH; DELEAGE JEAN; PENHOET EDWARD; GRUENER GARRETT; NOHRA GUY P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":226519.0,"shares_display":"226,519","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":2944747.0,"total_display":"2,944,747.00","shares_owned_after":1022064.0,"shares_owned_after_display":"1,022,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-12","filed_date":"2005-10-14","scope":"insider"},{"id":1481825,"accession":"0001209191-05-052406","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-052406","line_url":"/filing/0001209191-05-052406#line-2","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; ALTA PARTNERS II INC; MARDUEL ALIX; CHAMPSI FARAH; DELEAGE JEAN; PENHOET EDWARD; GRUENER GARRETT; NOHRA GUY P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15213.0,"shares_display":"15,213","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":197769.0,"total_display":"197,769.00","shares_owned_after":68638.0,"shares_owned_after_display":"68,638","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-12","filed_date":"2005-10-14","scope":"insider"},{"id":1481824,"accession":"0001209191-05-052406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-05-052406","line_url":"/filing/0001209191-05-052406#line-1","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; ALTA PARTNERS II INC; MARDUEL ALIX; CHAMPSI FARAH; DELEAGE JEAN; PENHOET EDWARD; GRUENER GARRETT; NOHRA GUY P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5582.0,"shares_display":"5,582","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":72566.0,"total_display":"72,566.00","shares_owned_after":25184.0,"shares_owned_after_display":"25,184","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-12","filed_date":"2005-10-14","scope":"insider"},{"id":9258772,"accession":"0001209191-04-049151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-04-049151","line_url":"/filing/0001209191-04-049151#line-1","is_derivative":false,"issuer_cik":"0001257444","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001257444","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT III LLC; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA BIOPHARMA PARTNERS III LP; ALTA CALIFORNIA MANAGEMENT PARTNERS III LLC; ALTA CALIFORNIA PARTNERS III LP; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; ALTA EMBARCADERO PARTNERS III LLC; JANNEY DANIEL","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":358426.0,"shares_display":"358,426","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2150556.0,"total_display":"2,150,556.00","shares_owned_after":2363263.0,"shares_owned_after_display":"2,363,263","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-10-15","filed_date":"2004-10-21","scope":"insider"},{"id":613682,"accession":"0001209191-04-048864","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-04-048864","line_url":"/filing/0001209191-04-048864#line-3","is_derivative":false,"issuer_cik":"0001138812","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001138812","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT III LLC; ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC; JANNEY DANIEL; ALTA CALIFORNIA MANAGEMENT PARTNERS III LLC; ALTA BIOPHARMA PARTNERS III LP; ALTA CALIFORNIA PARTNERS III LP; ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG; ALTA EMBARCADERO PARTNERS III LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":416666.0,"shares_display":"416,666","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2499996.0,"total_display":"2,499,996.00","shares_owned_after":2421503.0,"shares_owned_after_display":"2,421,503","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-10-15","filed_date":"2004-10-19","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001346830","name":"Cara Therapeutics, Inc.","url":"/issuer/0001346830","role":"Ten percent owner","n_filings":1,"first_seen":"2014-02-05","last_seen":"2014-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001338042","name":"Aegerion Pharmaceuticals, Inc.","url":"/issuer/0001338042","role":"Ten percent owner","n_filings":3,"first_seen":"2010-10-27","last_seen":"2012-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001061027","name":"SUNESIS PHARMACEUTICALS INC","url":"/issuer/0001061027","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2009-12-16","last_seen":"2010-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001183765","name":"THRESHOLD PHARMACEUTICALS INC","url":"/issuer/0001183765","role":"Other","n_filings":1,"first_seen":"2009-10-06","last_seen":"2009-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001070698","name":"TorreyPines Therapeutics, Inc.","url":"/issuer/0001070698","role":"Other","n_filings":1,"first_seen":"2009-09-08","last_seen":"2009-09-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001138812","name":"COTHERIX INC","url":"/issuer/0001138812","role":"Ten percent owner","n_filings":4,"first_seen":"2004-10-19","last_seen":"2005-10-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001257444","retrieved_at":"2026-08-21T00:08:53+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}